chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive for COVID; positive for COVID; This is a spontaneous report from a Pfizer Sponsored Program from a contactable consumer (patient). A 52-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EH9899, on 28Dec2020 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient took the first dose of the Pfizer COVID Vaccine on 28Dec2020. After that he showed positive for COVID. He was scheduled for the second dose today (18Jan2021). He had taken a COVID test and tested positive for COVID. He was trying to re-schedule an appointment. They told him to contact his doctor, which he did. His doctor had suggested that he took the second booster on 24Jan2021, instead of today. The patient took a covid test Last Friday (15Jan2021) and tested positive also, He didn't believe the results so he tested again today (18Jan2021) and the result was also positive. Both tests were rapid tests. What made him take the test, the following Wednesday, he had a dry cough. He took OTC cough medicine and it stopped the dry cough. No other symptoms, not coughing today. The outcome of the events was unknown.
[1] Lightheadedness: started 1 minute after vaccine, lasted 1-2 minutes. Relieved with meditative breathing; believed it to be anxiety related until seeing CDC produced list of symptoms from vaccine.  [2] Mild soreness, mild redness at injection site: started 4 hours after vaccine, lasted 24-36 hours.  [3] Felt feverish and flushed, arthralgia: started approximately 18 hours after vaccine (12/31/2020). "Fever" initially managed with Tylenol 650 mg. Later that evening took naproxen 440 mg to address arthralgia, which lasted about 2 days. No medication taken on 1/1/2021.
24 hours after vaccines mom noted redness around site worse next day with warmth, no tenderness Seen 10/5 redness there but improved
Abdominal pain started within 12 days, increasing in pain and severity over the next 3 days resulting in doctor visit.
About 7 hours after administration of vaccine patient experienced flu like symptoms including body aches, mild fever and chills. Also patient vomited and felt very run down, she also reported a very sore arm at injection site difficult to lift her arm even into this next day. She has tried taking tylenol and ibuprofen but still is experiencing symptoms she will follow up with me on when she has completely resolved.
This spontaneous report received from a patient, concerned a patient of unspecified age and gender. Medical history, weight, height, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch/lot number: not reported) dose, start therapy date: not reported, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient's allergies acted up. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome: not reported.
pt recvd vax & immediately devel hives over trunk, arms, legs, chest; no wheezing; pt recvd DPH;
Nausea, weakness, right arm in pain, extreme tiredness, black patches crossing left eye. Started two days after shot and lasted for 2 days. Bedridden for 2 days.
From July 2021, patient started hair loss. As of now (9/29/2021), there are quite large bald spots on patient's scalp.
This spontaneous report as received from a 67 years old female consumer with polymyalgia rheumatica and no drug reactions or allergies. The patient was vaccinated with a single 0.5 ml dose of PNEUMOVAX23 intramuscularly or subcutaneously (lot # not reported) on 05-OCT-2012. No other co-suspects were reported. Concomitant medications included: prednisone (manufacturer unknown) and unspecified blood pressure medication. On the same date, the patient experienced pain in her arm and shoulder after the injection. The patient said the pain was so severe that she could not move her arm. She did not contact her health care professional but self-medicated with "pain pill" and used ice. No lab diagnostics/studies were performed. The outcome of pain in her arm and shoulder was reported as recovering, the patient had regained mobility in arm. The relationship between the events and PNEUMOVAX23 was not reported. Additional information has been requested.
Chills; Aches; Temperature of 100.8; Stomach ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 27Apr2021 at 13:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease, and intravenous iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and pregnenolone (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously took alprazolam (XANAX) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient experienced chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Injection site arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site arm was very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE PAIN (Injection site arm was very sore). At the time of the report, VACCINATION SITE PAIN (Injection site arm was very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077891 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077891:Crosslinked with Mom's case (MOD21-076526)
About 30 minutes after shot while driving I got really dizzy and nauseous to the point I had to park. It lasted around an hour.; About 30 minutes after shot while driving I got really dizzy and nauseous to the point I had to park. It lasted around an hour.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 01Apr2021 at 11:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on 11Mar2021 at 11:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:15, reportedly about 30 minutes after shot while driving the patient got really dizzy and nauseous to the point he had to park. It lasted around an hour. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events dizzy and nauseous were recovered on 01Apr2021 at 13:15 after the duration of 1 hour.    No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist via company representative refers to a 70 year old female patient. Approximately in October 2013 (2 months ago), the patient was vaccinated with ZOSTAVAX (Lot number, expiry date, route and dose unknown) for vaccination. On unspecified dates within a week of administration of ZOSTAVAX, patient developed rash at her elbow and covered an unspecified area up her arms. It was reported that patient visited pharmacist and no treatment was given for rash. On an unspecified date, patient recovered from rash after a week adverse effect began. The outcome of rashes started at her elbow and covered an unspecified area up her arms was reported as recovered/resolved. No further information was provided. This case # 1312USA010015 is linked to case # 1312USA011728 via same reporter link. Additional information is not expected.
Temp Excursion - Yes; Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022; No adverse event; Erroneously vaccinated clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 49-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 017B22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022).    No concomitant medication was reported.  The date recd. was reported as 27-Jun-2022 and last date of vaccine administered was reported as 29-Jul-2022.  Before use date (refrigerator) was reported as 27-Jul-2022.  Patient received vaccine 2 days past expiry from vial of size 5.5 mL.  Vial had undergone the temperature excursion.  No treatment medication was reported.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 67-year-old male patient received BNT162b2 (BNT162B2), on 05Mar2021 at 13:00 as dose 1, single (Batch/Lot number: unknown) at the age of 66 years, in left arm, on 26Mar2021 at 13:00 as dose 2, single (Batch/Lot number: unknown), in left arm and on 27Oct2021 at 13:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine mRNA (mRNA 1273) (MODERNA COVID-19 VACCINE), on 05Apr2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Excessive stomach acid" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Levofloxacin, reaction(s): "Drug Allergy"; Likely many fluoroquinolones, reaction(s): "Drug allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: On the second day, I had a strongly positive Covid rapid test; Negative, notes: The day I took the last pills, I felt very good and had a negative Covid rapid test; Positive, notes: Four days later I had another strong positive rapid test and symptoms similar to a head cold returned for several days; Positive, notes: still have a significant positive rapid test and minor symptoms; Positive, notes: 4 days after start of Covid symptoms, I tested positive and was prescribed Paxlovid. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical information: 4 days after start of Covid symptoms, the patient tested positive and was prescribed Paxlovid. He completed the full course of Paxlovid tablets as prescribed. His condition improved, although it was already improving slightly when I received the pills. Over the next few days nearly all symptoms disappeared. On the second day, he had a strongly positive Covid rapid test. The day he took the last pills, he felt very good and had a negative Covid rapid test. Four days later he had another strong positive rapid test and symptoms similar to a head cold returned for several days. Yesterday, 8 days after finishing Paxlovid, he still have a significant positive rapid test and minor symptoms. he understand that this is not an unusual event. He report this just in case they are trying to get a variety of input on this. He does not consider this to be so much an adverse event as an unexpected event. He does not need any response. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever, almost 101 F; This non-serious case was reported by a consumer and described the occurrence of fever in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11-APR-2023, the patient received the 2nd dose of Shingrix. On 12-APR-2023, 1 days after receiving Shingrix, the patient experienced fever (Verbatim: Fever, almost 101 F). The outcome of the fever was not resolved.   The reporter considered the fever to be related to Shingrix.   The company considered the fever to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-APR-2023 The case was reported by patient's brother. The temperature was almost 101 degree F. The case had been linked to US2020AMR218334 and US2020AMR218281,reported by the same reporter, for a different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR218334:same reporter US-GLAXOSMITHKLINE-US2020AMR218281:same reporter
My periods have been irregular ever since getting the covid vaccines. Prior to this, I did not have any issues. I was schedule to get my period right  after the first dose. It did not come. After my second dose, my period was unusually long & heavy. Most periods following this have been irregular. My cycle length never returned back to normal. My periods frequently over 1 to 2 weeks late.  My PMS symptoms are also more significant than before the vaccine and my periods significantly heavier. My periods prior to getting the vaccines were always normal and I did not experience these types of problems.   Also worth noting is that I was unusually fatigued for 3 weeks after the 1st dose. I also became incredibly ill after the second dose, so much so that I considered going to the emergency room. I was shaking for hours. I could not regulate my body temperature. It was likely the sickest I have ever felt. I am not someone who is typically sensitive to vaccines and get the flu shot each year without issue.   It's been a year since my 2nd covid vaccine and I still experience period issues.
Pt called next day after injection saying her arm was red, swollen and itchy. Unable to lay on the side and her entire upper arm. Said it felt good the next day.
Sore arm, sick on stomach with vomiting, chills, achiness, tiredness  Two days  Bed rest and sleep required
Fever; Chills; Body aches; Joint pain; Headache very severe; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 15:45 (Lot number: 33130BA) at the age of 61 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "Chronic pain" (unspecified if ongoing); "depression" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose number=2, product=COVID 19, brand=Pfizer, lot number=EW0180, administration date=23Jun2021, vaccine location=Left arm), administration date: 23Jun2021, when the patient was 61 years old, for COVID-19 immunization; Bnt162b2 (Dose number=1, product=COVID 19, brand=Pfizer, lot number=EW0167, administration date=09May2021, vaccine location=Left arm), administration date: 09May2021, when the patient was 61 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 09Feb2022, outcome "recovering", described as "Fever"; CHILLS (non-serious) with onset 09Feb2022, outcome "recovering", described as "Chills"; PAIN (non-serious) with onset 09Feb2022, outcome "recovering", described as "Body aches"; ARTHRALGIA (non-serious) with onset 09Feb2022, outcome "recovering", described as "Joint pain"; HEADACHE (non-serious) with onset 09Feb2022, outcome "recovering", described as "Headache very severe". Therapeutic measures were not taken as a result of pyrexia, chills, pain, arthralgia, headache.  Additional information: No other vaccine in four weeks, Patient took other medications in two weeks, Patient was not diagnosed with COVID prior vaccination, Patient was not tested for COVID post vaccination and No Known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, fever, body chills, cold sweats. Headache is main concern lasting longer than 2 weeks, losing sleep. Other symptoms have also remained for 2 weeks. Tested negative for covid.
After the vaccine, I ran a low grade fever. Chills, and fatigue. I slept a few days. Nausea, fatigue fever, chills, swollen lymph nodes in the arm where the vaccine was given and headache. These symptoms all went away within a few days. I feel it was this bad just because I got the flu shot at the same time. After I was feeling better I took the shingle vaccine a week later. My stomach started to feel sick after this, and I was achy in my joints for a few days. By early October I was feeling fine, but then probably aroud mid October, I started to feel runned down. Then by the 15th and 16th I started urinating a lot and started throwing up a lot. I went to Urgent Care and I was diagnosed with a kidney infection. I am on antibiotics to treat it. I have heavy fatigue, pain in my lower back and in my stomach. I am, only eating liquids because solid food makes me vomit.
This spontaneous report as received from a consumer refers to a 61-year-old female patient who is allergic to sulfa. Patient had no pertinent medical history. On 14-NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and dose were not reported) subdermally. On the same day she also received Influenza Virus Vaccine (manufacturer unknown) (lot number, expiry date, dose and route were not reported). Concomitant medications included CLARINEX, vitamins (unspecified) Over-The-Counter (OTC), fish oil and glucosamine. On 14-NOV-2012, the patient went for swimming as usual and about 2-3 hours she started to experience wheezing, tightness in her chest, trembling, coughing and as well as chills. The symptoms lasted the entire night until the next morning. On 15-NOV-2012, the events wheezing, tightness in her chest, trembling, coughing and chills were resolved. The patient went swimming again 2 days later and the symptoms reappeared about 2-3 hours later. The patient attempted swimming on 2 more occasions and the exact thing appeared. On 03-DEC-2012, the patient went to the allergist and was prescribed VENTOLIN though she had no asthma. The patient reported that every time she went for swimming the same symptoms reappeared. She used VENTOLIN as directed and it only helped a little bit and very temporally. On 07-DEC-2012, about an hour ago of reporting, 08:30 MT (meridian time) the patient noticed a red rash that resembled a sun burn around the front part of her waist. The patient stated that the rash was not raised and was itching and burning and was also hot to touch. Blood work was done on 17-NOV-2012, everything came back normal. The outcome of the reported events were unknown. Patient did not seek medical attention and said she called the doctor and had an appointment on Monday. Additional information has been requested.
No additional AE; PROQUAD was administered after a temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 11-APR-2022, the patient was vaccinated with an improperly stored of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD)for prophylaxis (lot # U039254 has been verified to be a valid lot number measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and establish as 09-JUN-2023) (strength, dose, route of administration and anatomical location were not provided).  The temperature of storage and time frame of the excursion were 12.95° Fahrenheit (F) for 21 hours and 15 minutes respectively.  If a digital data logger was involved was not reported.  The vaccine did not experience a previous temperature excursion.  No adverse event reported.
Fever (101 degrees) Extreme chills Body aches  I took Tylenol and rested.  The symptoms abated after two days.
Patient is experiencing injection site reaction. Area of redness started as a small area, and today the area is larger than patient's handsize. Patient reports no raised areas or itching. Patient reports the area is warm to touch.
Headaches everyday, rashes all over, severe numbness on my left arm and hand,  severe fatigue, mood changes, sleep problems.